PAX4 Enhances Beta-Cell Differentiation of Human Embryonic Stem Cells
Author Information
Author(s): Liew Chee Gee, Shah Nadia N., Briston Sarah J., Shepherd Ruth M., Khoo Cheen Peen, Dunne Mark J., Moore Harry D., Cosgrove Karen E., Andrews Peter W.
Primary Institution: Centre for Stem Cell Biology, Department of Biomedical Science, The University of Sheffield, Sheffield, United Kingdom
Hypothesis
Can the transcription factor Pax4 drive the differentiation of human embryonic stem cells into beta-cells?
Conclusion
Constitutive expression of Pax4 in human embryonic stem cells significantly enhances their ability to form beta-cells.
Supporting Evidence
- Cells expressing key beta-cell markers were isolated by fluorescence-activated cell sorting.
- Constitutive expression of Pax4 significantly increased the expression of insulin and other beta-cell specific genes.
- H7.Px4 EBs showed enhanced functional responses to depolarization compared to untransfected H7 cells.
- Newport Green-positive cells from H7.Px4 EBs were enriched in insulin and Pdx1 mRNA expression.
- Sorted Newport Green-positive cells released C-peptide in response to tolbutamide.
Takeaway
Scientists found that adding a special protein called Pax4 helps stem cells turn into insulin-producing cells, which could help treat diabetes.
Methodology
The study involved stable transfection of Pax4 into human embryonic stem cells, followed by differentiation into embryoid bodies and analysis of gene expression and functional assays.
Limitations
The study does not address the long-term functionality of the derived beta-cells or their behavior post-transplantation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website